Authors
Year
Type of study
Patients
Pathology
Median OT (min)
Median EBL (ml)
Median Hb drop (g/dl)
IOC
POC
Median Hs (days)
Conversion
Lim et al. [13]
2009
Prospective
12
Benign adnexal tumors
73
(25–110)
10
NR
0
0
2
(2–3)
0
Kim et al. [14]
2009
Prospective
23
Adnexal masses
70
(40–128)
10
(10–100)
0
1
(1–3)
1
Lee et al. [15]
2009
Prospective
24
Myomas and adenomyosis
119
(90–255)
400
(100–1000)
NR
0
0
3
(3–7)
3
Fader et al. [16]
2009
Retrospective
4
Benign adnexal disease
47.5
(40–60)
NR
NR
0
0
0.5
0
Yoon et al. [12]
2010
Prospective
20
Ectopic pregnancy
55
(25–85)
NR
1.8
(0.3–2)
0
0
3
(2–4)
0
Lee et al. [17]
2010
Prospective, case control
17
Benign adnexal tumors
64
(33–148)
80
(10–200)
NR
0
0
2
(1–4)
0
Kim et al. [18]
2010
Retrospective, case control
43
Leiomyoma and adenomyosis
119 ± 32
369 ± 312
NR
0
0
2.8 ± 0.9
4
Yim et al. [19]
2010
Retrospective, comparative
52
Benign gynecological condition
117
(54–195)
100
(20–600)
NR
0
4
3.4
0
Jung et al. [20]
2010
Randomized prospective
34
Uterine fibroid, preinvasive cervical disease, adnexal lesions
89 ± 25.4
NR
NR
1
10
3.4
(3–4.3)
4
Kim et al. [21]
2010
Prospective
15
Myomas
96.7
(35–150)
NR
1.8
(0.4–3.6)
0
0
3.1
(0.8;2–4)
0
Escobar et al. [22]
2010
Case report
9
Benign adnexal pathology
NR
0–75
NR
0
0
1
1
Fader et al. [23]
2010
Retrospective
48
Benign pelvic mass and endometrial hyperplasia
43
25
(5–300)
NR
0
2
0
(0–3)
0
Song et al. [24]
2010
Prospective
15
Adenomyomas and myomas
125
(80–236)
500
(150–1,000)
NR
0
0
ND
2
Yoon et al. [25]
2010
Prospective
7
Myomas and adenomyomas
157
(140–233)
200
(100–300)
NR
0
0
4
(3–4)
0
Paek et al. [26]
2011
Retrospective
100
Benign disease (uterine and ovarian)
80
(41–185)
50
(10–600)
NR
0
8
3
(2–10)
0
Bedaiway et al. [11]
2011
Prospective
11
Ectopic pregnancy
35
(25–65)
30
(5–50)
NR
0
ND
8
(5–18)
0
Fagotti et al. [27]
2011
Prospective
28
Benign adnexal disease
39.5
(18–118)
10
(5–150)
NR
0
0
1.3 ± 0.5
2
Kim et al. [28]
2011
Retrospective
88
Benign disease
50.33 ± 13.26
42.83 ± 42.59
NR
6
2
1.94 ± 0.45
1
Fagotti et al. [29]
2011
Prospective, case control
27
Adnexal disease
38.5
(20–115)
20
(10–150)
NR
2
1
1
(1–3)
2
Yoon et al. [30]
2011
Prospective, case control
30
Ectopic pregnancy
52.6 ± 16.1
NR
1.7 ± 0.8
0
0
2.4 ± 0.5
0
Chen et al. [31]
2011
Prospective, randomized control trial
50
Benign pathology (leiomyoma, adenomyosis, endometrial hyperplasia, preinvasive cervical neoplasia)
122 ± 40
146 ± 124.8
NR
0
1
3.7 ± 0.7
2
Fagotti et al. [32]
2011
Prospective, randomized control trial
30
Benign adnexal disease
52
9.2
NR
0
1
1.3
0
Fanfani et al. [41]
2012
Retrospective cohort
14
Myoma, endometrial hyperplasia, adnexal masses
105
(75–125)
30
(10–80)
NR
1
0
1
(1–3)
1
Hoyer-Sorensen et al. [34]
2012
Prospective
40
Benign adnexal disease
42
50
NR
0
2
NR
NR
Cho et al. [35]
2012
Prospective randomized controlled study
33
Adnexal cyst
42.1
NR
2
0
2
ND
0
Han et al. [36]
2012
Prospective observational study
10
Uterine fibroids
196
(129–248.8)
100
(30–212.5)
NR
0
0
3
(2–4.3)
0
Kim et al. [37]
2013
Retrospective
63
Ectopic pregnancy
48.5 ± 10.6
1.4 ± 0.5
0
1
3.5 ± 0.9
0
Yim et al. [38]
2013
Retrospective, comparative
110
Benign adnexal disease
57.5
(41–91.3)
5
(5–50)
NR
0
4
2.1
NR
Choi et al. [39]
2013
Retrospective, comparative
120
Benign gynecological disease
73.1 ± 24.3
(35–180)
NR
1.7 ± 0.8
(0.2–4.4)
10
10
NR
0
Yoo et al. [40]
2013
Prospective
38
Benign adnexal mass
68
(45–180)
NR
2
0
1
NR
1
Fanfani et al. [33]
2013
Prospective randomized trial
17
Myoma, endometrial hyperplasia, adnexal masses
120
(55–155)
30
(10–300)
NR
0
0
2
(1–5)
2
Li et al. [42]
2013
Prospective randomized trial
52
Myomas
130.6 ± 15.2
(101.14–147.32)
158.27 ± 51.6
(70.01–270.23)
NR
0
13
5 ± 0.89
(4–7)
Related posts:
Single-Incision Laparoscopic Appendectomy
Single Access Laparoscopic Cholecystectomy
Single-Access Robotic Surgery
Single-Access Laparoscopic Approach for Pancreatic Surgery
Single-Access Laparoscopic Right Hemicolectomy
Single-Access Laparoscopic Approach for Gastric Surgery (Hiatal Hernia Repair and Gastric Resections)
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
Get Clinical Tree app for offline access
